Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2011-9-7
pubmed:abstractText
Pharmacokinetics of compound M-11 (main metabolite of afobazole) after administration via different routes was studied in rats. After oral and intravenous administration, M-11 exhibited weakly pronounced bioconversion with the formation of a few metabolites that could be detected in plasma samples for about 3 hours. The absolute bioavailability of M-11 after oral administration was 68.3%. It was found that M-11 was completely absorbed from gastrointestinal tract of rats and characterized by "the first pass effect", after which approximately 70% of administered dose entered the circulation. The parent substance was determined neither in urine nor in feces.
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0869-2092
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
22-6
pubmed:meshHeading
pubmed-meshheading:21894764-Animals, pubmed-meshheading:21894764-Anti-Anxiety Agents, pubmed-meshheading:21894764-Anxiety Disorders, pubmed-meshheading:21894764-Area Under Curve, pubmed-meshheading:21894764-Benzimidazoles, pubmed-meshheading:21894764-Biological Availability, pubmed-meshheading:21894764-Biotransformation, pubmed-meshheading:21894764-Chromatography, Liquid, pubmed-meshheading:21894764-Feces, pubmed-meshheading:21894764-Gastrointestinal Tract, pubmed-meshheading:21894764-Half-Life, pubmed-meshheading:21894764-Infusions, Parenteral, pubmed-meshheading:21894764-Injections, Intravenous, pubmed-meshheading:21894764-Limit of Detection, pubmed-meshheading:21894764-Male, pubmed-meshheading:21894764-Morpholines, pubmed-meshheading:21894764-Rats, pubmed-meshheading:21894764-Tandem Mass Spectrometry
pubmed:year
2011
pubmed:articleTitle
[Pharmacokinetics of afobazole metabolite (M-11) in rats].
pubmed:publicationType
Journal Article, English Abstract